204 related articles for article (PubMed ID: 15661212)
1. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.
Qayyum A; Coakley FV; Westphalen AC; Hricak H; Okuno WT; Powell B
Gynecol Oncol; 2005 Feb; 96(2):301-6. PubMed ID: 15661212
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer.
Lenhard SM; Burges A; Johnson TR; Kirschenhofer A; Bruns C; Linke R; Friese K
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):263-8. PubMed ID: 18614272
[TBL] [Abstract][Full Text] [Related]
3. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM
Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956
[TBL] [Abstract][Full Text] [Related]
4. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
Chi DS; Venkatraman ES; Masson V; Hoskins WJ
Gynecol Oncol; 2000 May; 77(2):227-31. PubMed ID: 10785469
[TBL] [Abstract][Full Text] [Related]
5. Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT.
Balestreri L; Bison L; Sorio R; Morra A; Campagnutta E; Morassut S
Radiol Med; 2002; 104(5-6):426-36. PubMed ID: 12589264
[TBL] [Abstract][Full Text] [Related]
6. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
[TBL] [Abstract][Full Text] [Related]
7. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
9. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
Li YF; Li MD; Liu FY; Liu JH; Li JD
Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
[TBL] [Abstract][Full Text] [Related]
10. Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer.
Gerestein CG; Eijkemans MJ; Bakker J; Elgersma OE; van der Burg ME; Kooi GS; Burger CW
Anticancer Res; 2011 Nov; 31(11):4043-9. PubMed ID: 22110240
[TBL] [Abstract][Full Text] [Related]
11. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI.
Kim HS; Kim JW; Cho JY; Chung HH; Park NH; Song YS; Kim SH; Kang SB
Eur J Surg Oncol; 2009 Aug; 35(8):870-6. PubMed ID: 19179039
[TBL] [Abstract][Full Text] [Related]
12. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
[TBL] [Abstract][Full Text] [Related]
13. Abdominal carcinomatosis in women with a history of breast cancer.
Garg R; Zahurak ML; Trimble EL; Armstrong DK; Bristow RE
Gynecol Oncol; 2005 Oct; 99(1):65-70. PubMed ID: 15979132
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R
Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
[TBL] [Abstract][Full Text] [Related]
15. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas.
Sadohara J; Fujimoto K; Müller NL; Kato S; Takamori S; Ohkuma K; Terasaki H; Hayabuchi N
Eur J Radiol; 2006 Oct; 60(1):70-9. PubMed ID: 16766154
[TBL] [Abstract][Full Text] [Related]
16. Ovarian carcinomatosis: how the radiologist can help plan the surgical approach.
Nougaret S; Addley HC; Colombo PE; Fujii S; Al Sharif SS; Tirumani SH; Jardon K; Sala E; Reinhold C
Radiographics; 2012 Oct; 32(6):1775-800; discussion 1800-3. PubMed ID: 23065169
[TBL] [Abstract][Full Text] [Related]
17. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
[TBL] [Abstract][Full Text] [Related]
18. A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer.
Gemer O; Lurian M; Gdalevich M; Kapustian V; Piura E; Schneider D; Lavie O; Levy T; Fishman A; Dgani R; Levavi H; Beller U
Eur J Surg Oncol; 2005 Nov; 31(9):1006-10. PubMed ID: 16005601
[TBL] [Abstract][Full Text] [Related]
19. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
20. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]